BioCentury
ARTICLE | Company News

Ipsen, Novartis deal

November 5, 2012 8:00 AM UTC

Ipsen said in its 3Q12 earnings that in April it terminated a January 2009 deal with Novartis to co-promote the pharma's Exforge amlodipine/valsartan in France to treat hypertension. Ipsen said the t...